US Patent 9650433 Modified glycoproteins
Patent 9650433 was granted and assigned to Momenta Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 18, 2012
Date of Patent
May 16, 2017
Patent Application Number
14118269
Patent Inventor Names
Sean Smith
0
Maurice Gaston Hains
0
Nathaniel J. Washburn
0
Naveen Bhatnagar
0
Brian Edward Collins
0
Carlos J. Bosques
0
Dorota A. Bulik
0
James Meador
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9650433 Modified glycoproteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.